Open Accessibility Menu

Clinical Trial Information

Role of Linagliptin in improving renal failure by improving CD34+ stem cell number, function and gene expression in renal function impaired type 2 diabetes patients.

Study Details

We are looking to see if Tradjenta, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin, Insulin, or BOTH Insulin and Metformin. Your HbA1C should be between 6.5 – 10 %.

Primary Sponsor:

Boehringer Ingelheim

Prinicipal Investigator:

Sabyasachi Sen

Contact Phone:

(202) 741-2342
Role of Linagliptin in improving renal failure by improving CD34+ stem cell number, function and gene expression in renal function impaired type 2 diabetes patients. fdore@mfa.gwu.edu

Interested in More Information

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please enter your address.
  • Please enter your city.
  • Please enter your state.
  • Please enter your zip code.
  • (All Uppercase. No Spaces)